Form CORRESP - Correspondence:
SEC Accession No. 0001493152-23-023970
Filing Date
2023-07-07
Accepted
2023-07-07 15:45:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 10731
  Complete submission text file 0001493152-23-023970.txt   11703
Mailing Address 217 W. MAIN STREET SOMERVILLE NJ 08876
Business Address 217 W. MAIN STREET SOMERVILLE NJ 08876 908-370-5102
ZyVersa Therapeutics, Inc. (Filer) CIK: 0001859007 (see all company filings)

EIN.: 862685744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations